Bing-Shiou Yang is a Ph.D. Chemical Engineer with 18+ years of pharmaceutical process development experiences in the areas of API isolation development, solid-state and engineering technologies. He is currently the Director of Solid-State Science & API Engineering in Material & Analytical Sciences (MAS) at BI in Ridgefield, CT, where he leads a multidisciplinary group that broadly impacts BI’s small molecule portfolio through scientific leadership and innovation in areas of crystallization, separation technology, continuous processing, process engineering and process analytical technology (PAT). He also leads multidisciplinary project team to streamline the DS and DP development interfaces based on solid form, API isolation process and material science profiling. Bing-Shiou represents BI in multiple working groups in International Consortium for Innovation and Quality (IQ) and Enabling Technology Consortium (ETC) and serves as Board of Director for the ETC.
Prior to BI, Bing-Shiou worked at Process Research and Development at Bristol-Myers Squibb (BMS) where he served as a crystallization and particle engineering specialist and had made significant contribution to portfolio compounds including ELIQUIS® (Apixaban). Bing-Shiou received his B.S. and M.E. degrees from National Taiwan University and Ph.D. in Chemical Engineering from Princeton University. Bing Shiou has co-authored over 60 publications, patents, book chapter and presentations